Yousef, Mohammad <br/><br/>
Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.  [electronic resource] 

 -  Pharmacological research  Jul 2012 
 - 66-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-1186 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2012.03.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetic Acid<br/>Acute Disease<br/>Administration, Oral<br/>Animals<br/>Anti-Inflammatory Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Cell Line<br/>Chitosan--administration & dosage<br/>Chronic Disease<br/>Colitis--chemically induced<br/>Colon--drug effects<br/>Dextran Sulfate<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Gastrointestinal Agents--administration & dosage<br/>Humans<br/>Inflammation Mediators--metabolism<br/>Inflammatory Bowel Diseases--chemically induced<br/>Interleukin-6--metabolism<br/>Intestinal Mucosa--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred ICR<br/>NF-kappa B--metabolism<br/>Oxidative Stress--drug effects<br/>Permeability<br/>Reactive Oxygen Species--metabolism<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--metabolism